Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 4, 2012, Pages 838-849

  Kocić, Jelena ^a   Santibañez, Juan F ^a   Krstić, Aleksandra ^a   Mojsilović, Slavko ^a   Dordević, Ivana Okić ^a   Trivanović, Drenka ^a   Ilić, Vesna ^a   Bugarski, Diana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

C2C12; ERK1,2; IL 17; Myoblast; Myogenic differentiation; Osteogenic differentiation

Indexed keywords

ALKALINE PHOSPHATASE; CYCLOOXYGENASE 2; INTERLEUKIN 17; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOGENIN; MYOSIN HEAVY CHAIN; TRANSCRIPTION FACTOR RUNX;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; INTERLEUKIN-17; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; MYOBLASTS; OSTEOGENESIS; RECEPTORS, INTERLEUKIN-17;

EID: 84857428138     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.01.001     Document Type: Article

References (53)

1. Gaffen S.L. An overview of IL-17 function and signaling. Cytokine 2008, 43:402-407.
2. Ivanov S., Lindén A. Interleukin-17 as a drug target in human disease. Trends Pharmacol. Sci. 2009, 30:95-103.
3. Xu S., Cao X. Interleukin-17 and its expanding biological functions. Cell. Mol. Immunol. 2010, 7:164-174.
4. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J.J., Garrone P., Garcia E., Saeland S., Blanchard D., Gaillard C., Das Mahapatra B., Rouvier E., Golstein P., Banchereau J., Lebecque S. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996, 183:2593-2603.
5. Jovcić G., Bugarski D., Petakov M., Krstić A., Vlaski M., Stojanović N., Milenković P. In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice. Cell. Prolif. 2004, 37:401-412.
6. Jovčić G., Bugarski D., Krstić A., Vlaški M., Petakov M., Mojsilović S., Stojanović N., Milenković P. The effect of interleukin-17 on hematopoietic cells and cytokine release in mouse spleen. Physiol. Res. 2007, 56:331-339.
7. Schwarzenberger P., Huang W., Ye P., Oliver P., Manuel M., Zhang Z., Bagby G., Nelson S., Kolls J.K. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 2000, 164:4783-4789.
8. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 2009, 9:556-567.
9. Bugarski D., Krstić A., Vlaski M., Petakov M., Jovcić G., Stojanović N., Milenković P. Interleukine-17-induced inhibitory effect on late stage murine erythroid bone marrow progenitors. Eur. Cytokine Netw. 2004, 15:247-254.
10. 2 concentrations enhance the positive effect of IL-17 on the maintenance of erythroid progenitors during co-culture of CD34+ and mesenchymal stem cells. Eur. Cytokine Netw. 2009, 20:10-16.
11. Huang H., Kim H.J., Chang E.-J., Lee Z.H., Hwang S.J., Kim H.-M., Lee Y., Kim H.-H. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell. Death. Differ. 2009, 16:1332-1343.
12. Shin J.H., Shin D.W., Noh M. Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochem. Pharmacol. 2009, 77:1835-1844.
13. Huang W., La Russa V., Alzoubi A., Schwarzenberger P. Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells. Stem Cells 2006, 24:1512-1518.
14. Chevrel G. Interleukin-17 increases the effects of IL-1β on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 2003, 137:125-133.
15. Tournadre A., Lenief V., Miossec P. Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum. 2010, 62:2144-2151.
16. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
17. Asakura A., Komaki M., Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.
18. Wada M.R., Inagawa-Ogashiwa M., Shimizu S., Yasumoto S., Hashimoto N. Generation of different fates from multipotent muscle stem cells. Development 2002, 129:2987-2995.
19. Aziz A., Miyake T., Engleka K., Epstein J., McDermott J.C. Menin expression modulates mesenchymal cell commitment to the myogenic and osteogenic lineages. Dev. Biol. 2009, 332:116-130.
20. Osses N., Casar J.C., Brandan E. Inhibition of extracellular matrix assembly induces the expression of osteogenic markers in skeletal muscle cells by a BMP-2 independent mechanism. BMC Cell Biol. 2009, 10:73.
21. Jaiswal R.K., Jaiswal N., Bruder S.P., Mbalaviele G., Marshak D.R., Pittenger M.F. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 2000, 275:9645-9652.
22. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 1995, 15:1858-1869.
23. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 2002, 277(7):4883-4891.
24. Romero D., Terzic A., Conley B.A., Craft C.S., Jovanovic B., Bergan R.C., Vary C.P. Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration. Carcinogenesis 2010, 31(3):359-366.
25. Li C.J., Chang J.K., Wang G.J., Ho M.L. Constitutively expressed COX-2 in osteoblasts positively regulates Akt signal transduction via suppression of PTEN activity. Bone 2011, 48:286-297.
26. Lian J.B., Stein G.S. Runx2/Cbfa1: a multifunctional regulator of bone formation. Curr. Pharm. Des. 2003, 9:2677-2685.
27. Kim H.J., Kim S.H. Tanshinone IIA enhances BMP-2-stimulated commitment of C2C12 cells into osteoblasts via p38 activation. Amino Acids 2010, 39:1217-1226.
28. Luo J., Tang M., Huang J., He B.C., Gao J.L., Chen L., Zuo G.W., Zhang W., Luo Q., Shi Q., Zhang B.Q., Bi Y., Luo X., Jiang W., Su Y., Shen J., Kim S.H., Huang E., Gao Y., Zhou J.Z., Yang K., Luu H.H., Pan X., Haydon R.C., Deng Z.L., He T.C. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J. Biol. Chem. 2010, 285(38):29588-29598.
29. Leloup L., Daury L., Mazères G., Cottin P., Brustis J.-J. Involvement of the ERK/MAP kinase signalling pathway in milli-calpain activation and myogenic cell migration. Int. J. Biochem. Cell Biol. 2007, 39:1177-1189.
30. Morgan J. Muscle satellite cells. Int. J. Biochem. Cell Biol. 2003, 35:1151-1156.
31. Lee S.J., Lee E.J., Kim S.H., Choi I., Lee D.M., Lee H.J., Yoon D., Chun T. IL-17A promotes transdifferentiation of mouse myoblast cells (C2C12) into adipocytes by increasing the expression of peroxisome proliferator-activated receptor γ through CAAT/enhancer binding protein β signaling. Biotechnol. Lett. 2011, 33:229-235.
32. Yi C., Liu D., Fong C.-C., Zhang J., Yang M. Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway. ACS Nano 2010, 4:6439-6448.
33. Komori T. Requisite roles of Runx2 and Cbfa in skeletal development. J. Bone Miner. Metab. 2003, 21:193-197.
34. Gersbach C., Byers B., Pavlath G.K., García A.J. Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp. Cell. Res. 2004, 300:406-417.
35. Dubois R.N., Abramson S.B., Crofford L., Gupta R., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12:1063-1073.
36. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 2002, 109:1405-1415.
37. Keren A., Tamir Y., Bengal E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 2006, 252:224-230.
38. Gallea S., Lallemand F., Atfi A., Rawadi G., Ramez V., Spinella-Jaegle S., Kawai S., Faucheu C., Huet L., Baron R., Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 2001, 28:491-498.
39. Arita N., Pelaez D., Cheung H.S. Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGFβ-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2011, 405:564-569.
40. Yang W., Chen Y., Zhang Y., Wang X., Yang N., Dahai Z. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Res. 2006, 66:1320-1326.
41. Krstić A., Ilić V., Mojsilović S., Jovcić G., Milenković P., Bugarski D. p38 MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells. Growth Factors 2009, 27:79-90.
42. Huang Z., Chen D., Zhang K., Yu B., Chen X., Meng J. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cell 2007, 19:2286-2295.
43. Xiao G., Jiang D., Thomas P., Benson M.D., Guan K., Karsenty G., Franceschi R.T. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 2000, 275:4453-4459.
44. Ge C., Xiao G., Jiang D., Yang Q., Hatch N.E., Roca H., Franceschi R.T. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J. Biol. Chem. 2009, 284:32533-32543.
45. Deschaseaux F., Sensébé L., Heymann D. Mechanisms of bone repair and regeneration. Trends Mol. Med. 2009, 15:417-429.
46. Oh C.D., Chang S.H., Yoon Y.M., Lee S.J., Lee Y.S., Kang S.S., Chun J.S. Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J. Biol. Chem. 2000, 275:5613-5619.
47. Santibañez J.F., Quintanilla M., Bernabeu C. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond). 2011, 121(6):233-251.
48. Zilberberg L., ten Dijke P., Sakai L.Y., Rifkin D.B. A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol. 2007, 8:41.
49. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., Miossec P. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999, 42:963-970.
50. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin T.J., Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999, 103:1345-1352.
51. Hashimoto N., Kiyono T., Wada M.R., Umeda R., Y-ichi Goto, Nonakae I., Shimizuf S., Yasumotog S., Inagawa-Ogashiwaa M. Osteogenic properties of human myogenic progenitor cells. Mech. Dev. 2007, 125:257-269.
52. McCarthy E.F., Sundaram M. Heterotopic ossification: a review. Skeletal Radiol. 2005, 34:609-619.
53. Rifas L., Arackal S., Weitzmann M.N. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J. Cell. Biochem. 2003, 88:650-659.